Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies. Lazar, V., Raymond, E., GIRARD, N., Martini, J., Galbraith, S., Raynaud, J., Bresson, C., Solomon, B., Magidi, S., Nechushtan, H., & others
bibtex   
@article{lazartranscriptomics,
  title={Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies},
  author={Lazar, Vladimir and Raymond, Eric and GIRARD, Nicolas and Martini, Jean-Fran{\c{c}}ois and Galbraith, Susan and Raynaud, Jacques and Bresson, Catherine and Solomon, Benjamin and Magidi, Shai and Nechushtan, Hovav and others}
}

Downloads: 0